Long-term clinical outcomes of a phase I trial of intravesical docetaxel in the management of non-muscle-invasive bladder cancer refractory to standard intravesical therapy.

Urology
Melissa A LaudanoJames M McKiernan

Abstract

To report the long-term clinical outcomes and durability of response after treatment with induction intravesical docetaxel. Most novel agents used to treat bacillus Calmette-Guerin refractory high-grade non-muscle-invasive (NMI) bladder cancer are evaluated only after short follow-up periods. Our previously published phase I trial demonstrated that docetaxel is a safe agent for intravesical therapy with minimal toxicity and no detectable systemic absorption. We sought to determine long-term clinical outcomes after treatment with intravesical docetaxel. Eighteen patients with recurrent Ta (n = 7), T1 (n = 5), and Tis (n = 6) transitional cell carcinoma who experienced treatment failure with at least 1 prior intravesical therapy completed the phase I trial. Docetaxel was administered as 6 weekly intravesical instillations using a dose-escalation model terminated at 0.75 mg/mL. Efficacy was evaluated by interval cystoscopy with biopsies when indicated, cytology, and computed tomography imaging. Follow-up consisted of quarterly cystoscopy, cytology, computed tomography, and biopsy when indicated. With a median follow-up of 48.3 months, 4 patients (22%) have demonstrated a complete durable response and currently remain disease-free ...Continue Reading

References

Jan 1, 1994·Cancer Chemotherapy and Pharmacology·C RangelC Cox
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James M McKiernanMitchell C Benson
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Oct 5, 2010·Chaos·Joseph T LizierAlbert Y Zomaya
May 31, 2012·Advances in Urology·Daniel A BarocasRachel J Spear
Jun 13, 2014·Current Opinion in Urology·Jennifer J AhnJames M McKiernan
Sep 13, 2013·Der Urologe. Ausg. A·M BöhmUNKNOWN Arbeitskreis Urinzytologie der DGU (Deutsche Gesellschaft für Urologie)
Jul 20, 2010·Immunotherapy·Shahrokh F ShariatGuido Dalbagni
May 15, 2012·Der Urologe. Ausg. A·J M LaturnusM Sommerauer
Nov 30, 2010·World Journal of Urology·Alon Z WeizerJeffrey S Montgomery
Nov 30, 2010·Expert Review of Anticancer Therapy·Rianne J M Lammers, J Alfred Witjes
Nov 17, 2015·Expert Review of Anticancer Therapy·Pranav SharmaWade J Sexton
Oct 31, 2013·Expert Review of Anticancer Therapy·Anna V van LingenJ Alfred Witjes
Aug 21, 2013·Expert Opinion on Biological Therapy·Anna V van Lingen, J Alfred Witjes
Apr 2, 2013·The Urologic Clinics of North America·David C JohnsonMichael E Woods
Apr 2, 2013·The Urologic Clinics of North America·Jennifer J Ahn, James M McKiernan
Oct 9, 2012·Seminars in Oncology·Vinod H NargundM N Kabir
Mar 2, 2017·Nature Reviews. Urology·Ashish M KamatJ Alfred Witjes
Feb 15, 2019·Current Opinion in Urology·Melanie R HasslerFrancesco Soria
Nov 12, 2010·Cancer Chemotherapy and Pharmacology·Antonia TsallasHelen Burt
Aug 16, 2019·Expert Opinion on Investigational Drugs·Jennifer TseVitaly Margulis
Aug 23, 2019·Nature Reviews. Urology·Gregory A JoiceMax Kates
Nov 30, 2019·Family Process·Judith P Siegel
May 20, 2020·Current Opinion in Urology·Francesco SoriaPaolo Gontero
Feb 5, 2013·Current Urology Reports·LaMont J Barlow, Mitchell C Benson
Sep 12, 2020·Expert Review of Anticancer Therapy·Mohamad MoussaWajih Saad
Oct 1, 2019·Current Opinion in Urology·Francesca PisanoJ Palou
Dec 12, 2018·World Journal of Urology·Charles C PeytonPhillippe E Spiess
Jun 5, 2021·Investigative and Clinical Urology·Hyung Suk Kim, Ho Kyung Seo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.